A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Amgen Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 574,972 shares of AMGN stock, worth $186 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
574,972
Previous 375,457 53.14%
Holding current value
$186 Million
Previous $107 Million 68.29%
% of portfolio
0.46%
Previous 0.28%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$262.75 - $319.31 $52.4 Million - $63.7 Million
199,515 Added 53.14%
574,972 $180 Million
Q1 2024

May 08, 2024

SELL
$268.87 - $324.56 $44.6 Million - $53.8 Million
-165,853 Reduced 30.64%
375,457 $107 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $4.08 Million - $4.61 Million
-15,972 Reduced 2.87%
541,310 $156 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $10.3 Million - $12.8 Million
47,125 Added 9.24%
557,282 $150 Million
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $9.54 Million - $11.3 Million
-44,538 Reduced 8.03%
510,157 $113 Million
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $13.2 Million - $16.1 Million
-58,435 Reduced 9.53%
554,695 $134 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $4.21 Million - $5.35 Million
18,398 Added 3.09%
613,130 $161 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $4 Million - $4.52 Million
17,841 Added 3.09%
594,732 $134 Million
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $22.5 Million - $25 Million
97,361 Added 20.3%
576,891 $140 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $50.5 Million - $55.9 Million
230,389 Added 92.47%
479,530 $116 Million
Q4 2021

Feb 09, 2022

SELL
$198.88 - $227.6 $19.3 Million - $22.1 Million
-96,913 Reduced 28.01%
249,141 $56 Million
Q3 2021

Nov 08, 2021

SELL
$212.27 - $248.7 $5.3 Million - $6.21 Million
-24,975 Reduced 6.73%
346,054 $73.6 Million
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $1.1 Million - $1.22 Million
-4,703 Reduced 1.25%
371,029 $90.4 Million
Q1 2021

May 05, 2021

SELL
$221.91 - $258.6 $7.26 Million - $8.46 Million
-32,709 Reduced 8.01%
375,732 $93.5 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $6.86 Million - $8.16 Million
31,684 Added 8.41%
408,441 $93.9 Million
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $6.91 Million - $7.69 Million
29,459 Added 8.48%
376,757 $95.8 Million
Q2 2020

Aug 04, 2020

SELL
$197.81 - $242.74 $1.68 Million - $2.06 Million
-8,502 Reduced 2.39%
347,298 $81.9 Million
Q1 2020

May 12, 2020

BUY
$182.24 - $241.7 $9.96 Million - $13.2 Million
54,672 Added 18.16%
355,800 $72.1 Million
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $14.5 Million - $18.6 Million
76,661 Added 34.15%
301,128 $72.6 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $7.41 Million - $8.88 Million
42,557 Added 23.39%
224,467 $43.4 Million
Q2 2019

Aug 02, 2019

SELL
$166.7 - $195.41 $14.4 Million - $16.9 Million
-86,489 Reduced 32.22%
181,910 $33.5 Million
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $26.9 Million - $30.3 Million
148,549 Added 123.95%
268,399 $51 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $8.16 Million - $9.52 Million
45,728 Added 61.69%
119,850 $22.9 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $3.97 Million - $4.47 Million
-21,421 Reduced 22.42%
74,122 $15.4 Million
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $2.32 Million - $2.6 Million
-13,965 Reduced 12.75%
95,543 $17.6 Million
Q1 2018

May 07, 2018

SELL
$169.43 - $198.0 $2.24 Million - $2.62 Million
-13,227 Reduced 10.78%
109,508 $18.7 Million
Q4 2017

Feb 01, 2018

BUY
$168.79 - $188.59 $2.2 Million - $2.46 Million
13,049 Added 11.9%
122,735 $21.3 Million
Q3 2017

Nov 02, 2017

BUY
$167.29 - $191.0 $18.3 Million - $21 Million
109,686
109,686 $20.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.